Greenland Mines Stock Price, News & Analysis
Company Description
Greenland Mines (NASDAQ: GRMLW) is a publicly traded company in the Biological Products, (no Diagnostic Substances) sector.
GRMLW stock has gained 89.7% over the past year. Shares last traded at $0.2621.
On a trailing twelve-month basis, Greenland Mines reported net income of -$10.6M and diluted earnings per share of $-0.22.
This page provides a comprehensive overview of GRMLW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Greenland Mines (GRMLW) stock last traded at $0.2621, up 2.94% from the previous close. Over the past 12 months, the stock has gained 89.7%.
GRMLW Rankings
Latest News
SEC Filings
Greenland Mines has filed 10 recent SEC filings, including 6 Form 8-K, 2 Form NT 10-Q, 2 Form 10-K. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GRMLW SEC filings →
Financial Highlights
operating income reached -$7.1M, and net income was -$10.6M. Diluted earnings per share stood at $-0.22. The company generated -$5.9M in operating cash flow. With a current ratio of 95.01, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Greenland Mines (GRMLW) currently stands at 41.0 thousand shares, down 15.0% from the previous reporting period.
Days to Cover History
Days to cover for Greenland Mines (GRMLW) currently stands at 3.2 days, down 50.4% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 31.4% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 2.5 to 6.5 days.
GRMLW Company Profile & Sector Positioning
Greenland Mines (GRMLW) operates in the Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.